Voices
Aya Mohamed: Benefit of Prolonged Endocrine Therapy
Aya Mohamed/X

Aya Mohamed: Benefit of Prolonged Endocrine Therapy

Aya Mohamed, Medical Oncologist, Associate Lecturer of Medical Oncology, Member of ASCO, shared a post on X:

“Journal of Clinical Oncology cohort study: Extending endocrine therapy after 5 years of LHRHa in premenopausal node-positive HR+ eBC reduced invasive and distant recurrences.

5-y IBCFS: 85% vs 78% (HR 0.63)

5-y DRFS: 91% vs 83% (HR 0.49)

Low toxicity.”

Title: Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study

Authors: Carmine Valenza, Yue Zheng, Monica Milano, Dario Trapani, Elisa Giordano, Lorenzo Guidi, Pier Paolo Maria Berton Giachetti, Laura Boldrini, Grazia Castellano, Jalissa Katrini, Bianca Malagutti, Gabriele Antonarelli, Fabio Conforti, Eleonora Pagan, Vincenzo Bagnardi, Gregory J. Kirkner, Claudia Sangalli, Kate E. Dibble, Marco Colleoni, Meredith M. Regan, Elisabetta Munzone, Giuseppe Curigliano, Ann H. Partridge

Read the Full Article.

Aya Mohamed: Benefit of Prolonged Endocrine Therapy

More posts featuring Aya Mohamed on OncoDaily.

Ann H. Partridge Aya Mohamed Bianca Malagutti Carmine Valenza Claudia Sangalli Dario Trapani Eleonora Pagan Elisa Giordano Elisabetta Munzone Fabio Conforti Gabriele Antonarelli Giuseppe Curigliano Grazia Castellano Gregory J. Kirkner Jalissa Katrini Journal of Clinical Oncology Kate E. Dibble Laura Boldrini Lorenzo Guidi Marco Colleoni Meredith M Regan Monica Milano Pier Paolo Maria Berton Giachetti Vincenzo Bagnardi Yue Zheng